Pacira BioSciences Inc (PCRX)

Add to Watchlists
Create an Alert
43.75 +0.97  +2.27% NASDAQ Jun 18, 16:59 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/02/2019 08:30 EDT Misc Pacira Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2019
08/02/2019 Earnings Pacira Pharmaceuticals Inc Second Quarter Earnings in 2019 Release
06/04/2019 14:00 EDT Misc Pacira Pharmaceuticals Inc Annual General Meeting in 2018
05/02/2019 08:30 EDT Misc Pacira BioSciences Inc First Quarter Earnings Conference Call in 2019
05/02/2019 Earnings Pacira Pharmaceuticals Inc First Quarter Earnings in 2019 Release
02/28/2019 08:30 EST Misc Pacira Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2018
02/28/2019 Earnings Pacira Pharmaceuticals Inc Fourth Quarter Earnings in 2018 Release
02/28/2019 Misc Pacira Pharmaceuticals Inc Annual Report in 2018
11/01/2018 08:30 EDT Misc Pacira Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2018
11/01/2018 Earnings Pacira Pharmaceuticals Inc Third Quarter Earnings Results in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.pacira.com
  • Investor Relations URL: http://investor.pacira.com/phoenix.zhtml?c=220759&p=irol-irhome
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Aug. 02, 2019
  • Last Earnings Release: May. 02, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company have launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.

Top Fund Holders

Symbol Name Weighting
F000013IKL FT Sabrient Baker's Dozen Apr 2019 F CA 9.30%
F000013N4M FT Sabrient Baker's Dozen May 2019 CA 7.45%
DFZRX Delaware Smid Cap Growth R6 3.96%
DSGEX Delaware Small Cap Growth C 3.77%
SPYGX Spyglass Growth Institutional 3.46%
XPH SPDR® S&P Pharmaceuticals ETF 2.94%
PILL Direxion Daily Phrmctcl&MdclBl3XShrsETF 2.22%
FTXH First Trust Nasdaq Pharmaceuticals ETF 1.96%
HISOX Harbor Small Cap Growth Opps Inv 1.53%
PXSG Invesco Russell 2000 Pure Growth ETF 1.08%
IHE iShares US Pharmaceuticals ETF 0.79%

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("PCRX","name")
  • Description: =YCI("PCRX","description")
  • Sector: =YCI("PCRX","sector")
  • Industry: =YCI("PCRX","industry")
  • Est. Current Fiscal Year End: =YCI("PCRX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.